Table 3.
AD | MCI-stable | HC | p value | |
---|---|---|---|---|
Delta (1–4 Hz) | 0.27 (0.17–0.34) | 0.28 (0.23–0.29) | 0.27 (0.19–0.32) | n.s. |
Theta (4–8 Hz) | 0.24 (0.18–0.29) | 0.18 (0.14–0.21) | 0.15 (0.13–0.21) | <0.01* |
Alpha1 (8–10 Hz) | 0.18 (0.11–0.32) | 0.17 (0.16–0.29) | 0.21 (0.12–0.31) | n.s. |
Alpha2 (10–13 Hz) | 0.09 (0.07–0.13) | 0.14 (0.12–0.15) | 0.12 (0.09–0.15) | n.s. |
Beta (13–30 Hz) | 0.16 (0.13–0.22) | 0.2 (0.18–0.23) | 0.21 (0.17–0.26) | 0.03 |
Median frequency | 8.35 (8.17–8.92) | 8.99 (8.88–9.26) | 8.96 (8.54–9.29) | <0.01* |
AD patients with Alzheimer’s disease, MCI-stable patients with stable or improving cognition over 30 months, HC healthy controls, n.s. not significant
Data presented are median (interquartile range)
*p < 0.05 by t test for AD vs. MCI-stable, representing statistically significant result